Introduction
• Cefovecin (ConveniaTM, Pfizer Animal Health) is a semi-synthetic 3 rd generation cephalosporin recently developed for use in dogs and cats
• Cefovecin has in previous studies been shown to have an exceptional long elimination half-life in dogs (136 ± 10 h.) 1 and cats (166 ± 18 h.) 2 , making it suitable for antibacterial treatment with a 14-day dosing interval in these species
• A single-injection treatment will reduce stress in animal species sensitive to stress from handling and restraint such as reptiles
Results

Pharmacokinetic parameters for cefovecin in hens
• Cefovecin was characterized by rapid absorption with peak plasma concentration of 6 ± ± ± ± 2 µ µ µ µg/mL within 20 min. of subcutaneous injection
•Mean plasma half-life was 52 ± ± ± ± 16 minutes after subcutaneous injection
•Volume of distribution was 1.6 ± ± ± ± 0,5 L/Kg and clearance was 21 ± ± ± ± 3 mL/min/Kg (Both parameters calculated with the bioavailability set to be 100 %) Subcutaneous injection from handling and restraint such as reptiles and birds .
•The aim of this study was therefore to determine the plasma-half-life for cefovecin in hens and green iguanas to establish whether cefovecin is a suitable antibiotic for singleinjection treatment of bacterial infections in these species
Materials and methods
Discussion
•Concentrations of cefovecin in plasma obtained from bird species in the preliminary study were similar to concentrations in hens
•More dissimilarities were observed between reptile species, indicating a larger variance in pharmacokinetic parameters in these species
•Possible reasons for variation of pharmacokinetics for cefovecin in different species include:
• diversity in P450 isoenzymes
• variations in protein binding
• renal physiologic and anatomic differences
•There is still a good possibility that there are other stress sensitive animal species for which
Pharmacokinetic parameters for cefovecin in green iguanas
•Mean plasma half-life was 3.9 hours after subcutaneous injection
•Volume of distribution was 0.3 l/Kg and clearance was 53 mL/hour/Kg after subcutaneous injection (Parameters calculated with the bioavailability set to be 100 %) other stress sensitive animal species for which cefovecin will be a good choice for antibiotic treatment
•There is a need to identify broad-spectrum antibiotics with long elimination half-lives that can be used in wildlife and zoo animals to reduce the stress these animals experience in relation to medical care
Conclusion
•Cefovecin is not suitable for treatment of bacterial infections with a single-injection dosing regime in hens or green iguanas.
•It is unlikely that cefovecin is suitable for treatment of bacterial infections i any species of birds 
